Comparative Pharmacology
Head-to-head clinical analysis: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE versus TEVETEN HCT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE versus TEVETEN HCT.
OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE vs TEVETEN HCT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Olmesartan medoxomil is an angiotensin II receptor blocker (ARB) that selectively inhibits angiotensin II binding to AT1 receptors, reducing vasoconstriction and aldosterone secretion. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, increasing diuresis and lowering blood pressure.
TEVETEN HCT combines eprosartan mesylate, an angiotensin II receptor antagonist, and hydrochlorothiazide, a thiazide diuretic. Eprosartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively antagonizing the AT1 receptor. Hydrochlorothiazide inhibits the sodium-chloride symporter in the distal convoluted tubule, increasing excretion of sodium, chloride, and water, thereby reducing plasma volume.
Oral, one tablet once daily. Starting dose: Olmesartan medoxomil 20 mg / hydrochlorothiazide 12.5 mg. Titrate up to maximum 40 mg / 25 mg daily as needed.
One tablet orally once daily, containing eprosartan 600 mg and hydrochlorothiazide 12.5 mg or 25 mg, with or without food. Maximum dose: eprosartan 600 mg/hydrochlorothiazide 25 mg per day.
None Documented
None Documented
Olmesartan: terminal half-life ~10–15 hours; no accumulation. Hydrochlorothiazide: terminal half-life ~6–15 hours; prolonged in renal impairment.
Eprosartan: 5-9 hours; Hydrochlorothiazide: 6-15 hours; allows once-daily dosing.
Olmesartan: ~60% renal, ~35% fecal. Hydrochlorothiazide: ~70% renal (unchanged), ~30% biliary/fecal.
Eprosartan: renal (70% unchanged, 10% as metabolite), biliary/fecal (20%); Hydrochlorothiazide: renal (≥95% unchanged).
Category D/X
Category C
ARB
ARB + Thiazide Diuretic Combination